CA2250192A1 - Inhibiteurs de farnesyle-proteine transferase - Google Patents
Inhibiteurs de farnesyle-proteine transferase Download PDFInfo
- Publication number
- CA2250192A1 CA2250192A1 CA002250192A CA2250192A CA2250192A1 CA 2250192 A1 CA2250192 A1 CA 2250192A1 CA 002250192 A CA002250192 A CA 002250192A CA 2250192 A CA2250192 A CA 2250192A CA 2250192 A1 CA2250192 A1 CA 2250192A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- aryl
- hydrogen
- independently selected
- heterocycle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés inhibant la farnésyle-protéine transférase (FTase) ainsi que la farnésylation de la protéine Raz oncogène. L'invention concerne également des compositions chimiothérapeutiques contenant les composés de ladite invention ainsi que des méthodes inhibant la farnésyle-protéine transférase et la farnésylation de la protéine Ras oncogène.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1477796P | 1996-04-03 | 1996-04-03 | |
US60/014,777 | 1996-04-03 | ||
GBGB9616736.6A GB9616736D0 (en) | 1996-07-09 | 1996-07-09 | Inhibitors of farnesyl-protein transferase |
GB9616736.6 | 1996-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2250192A1 true CA2250192A1 (fr) | 1997-10-09 |
Family
ID=26309841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002250192A Abandoned CA2250192A1 (fr) | 1996-04-03 | 1997-03-27 | Inhibiteurs de farnesyle-proteine transferase |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0891353A4 (fr) |
JP (1) | JP2000507581A (fr) |
AU (1) | AU716153B2 (fr) |
CA (1) | CA2250192A1 (fr) |
WO (1) | WO1997036892A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0880320A4 (fr) * | 1996-01-30 | 1999-06-16 | Merck & Co Inc | Inhibiteurs de la farnesyl-proteine transferase |
US6297239B1 (en) * | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
ATE229017T1 (de) * | 1998-02-02 | 2002-12-15 | Lg Chemical Ltd | Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung |
FR2780892B1 (fr) * | 1998-07-08 | 2001-08-17 | Sod Conseils Rech Applic | Utilisation d'inhibiteurs de prenyltransferases pour preparer un medicament destine a traiter les pathologies qui resultent de la fixation membranaire de la proteine g heterotrimerique |
US7129359B2 (en) | 2002-07-09 | 2006-10-31 | National Health Research Institutes | Imidazolidinone compounds |
US7259174B2 (en) | 2004-05-25 | 2007-08-21 | National Health Research Institutes | Imidazolidinone compounds |
PE20080942A1 (es) | 2006-06-20 | 2008-09-03 | Wyeth Corp | Compuestos 1-n-amino-2-imidazolidinonas como inhibidores del canal de potasion kv1.5 |
US8637560B2 (en) | 2007-07-18 | 2014-01-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment |
US8518968B2 (en) | 2009-12-04 | 2013-08-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hydrazone and diacyl hydrazine compounds and methods of use |
JP2014040374A (ja) * | 2010-12-15 | 2014-03-06 | Taisho Pharmaceutical Co Ltd | グリシントランスポーター阻害物質 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3020276A (en) * | 1958-03-03 | 1962-02-06 | Petrolite Corp | Cyclic amidines |
US4661602A (en) * | 1985-03-29 | 1987-04-28 | G. D. Searle & Co. | Substituted alkyl imidazole derivatives |
US4810800A (en) * | 1986-05-06 | 1989-03-07 | Merrell Dow Pharmaceuticals Inc. | Novel imidazole dopamine beta hydroxylase inhibitors |
JPH09504277A (ja) * | 1993-09-30 | 1997-04-28 | メルク エンド カンパニー インコーポレーテッド | ファルネシル−タンパク質トランスフェラーゼの阻害剤 |
US5439918A (en) * | 1994-03-14 | 1995-08-08 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
WO1996010034A2 (fr) * | 1994-09-29 | 1996-04-04 | Merck & Co., Inc. | Inhibiteurs de la transferase de proteines farnesylees exempts de thiol |
IL117580A0 (en) * | 1995-03-29 | 1996-07-23 | Merck & Co Inc | Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them |
-
1997
- 1997-03-27 CA CA002250192A patent/CA2250192A1/fr not_active Abandoned
- 1997-03-27 AU AU25932/97A patent/AU716153B2/en not_active Ceased
- 1997-03-27 WO PCT/US1997/005060 patent/WO1997036892A1/fr not_active Application Discontinuation
- 1997-03-27 EP EP97917669A patent/EP0891353A4/fr not_active Withdrawn
- 1997-03-27 JP JP09535441A patent/JP2000507581A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2593297A (en) | 1997-10-22 |
EP0891353A4 (fr) | 2001-08-08 |
AU716153B2 (en) | 2000-02-17 |
EP0891353A1 (fr) | 1999-01-20 |
WO1997036892A1 (fr) | 1997-10-09 |
JP2000507581A (ja) | 2000-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU704087B2 (en) | Inhibitors of farnesyl-protein transferase | |
US6066738A (en) | Inhibitors of farnesyl-protein transferase | |
US5968965A (en) | Inhibitors of farnesyl-protein transferase | |
US5925651A (en) | Inhibitors of farnesyl-protein transferase | |
US5780492A (en) | Inhibitors of farnesyl-protein transferase | |
AU712504B2 (en) | Inhibitors of farnesyl-protein transferase | |
CA2250353A1 (fr) | Inhibiteurs de la farnesyl-proteine transferase | |
AU715667B2 (en) | Inhibitors of farnesyl-protein transferase | |
CA2249559A1 (fr) | Inhibiteurs de farnesyle-proteine transferase | |
AU706495B2 (en) | Inhibitors of farnesyl-protein transferase | |
WO1997036886A1 (fr) | Inhibiteurs de la farnesyl-proteine transferase | |
AU707416B2 (en) | Inhibitors of farnesyl-protein transferase | |
AU2660797A (en) | Inhibitors of farnesyl-protein transferase | |
AU716153B2 (en) | Inhibitors of farnesyl-protein transferase | |
AU703988B2 (en) | Inhibitors of farnesyl-protein transferase | |
US6028201A (en) | Inhibitors of farnesyl-protein transferase | |
WO1997036584A1 (fr) | Inhibiteurs de transferase de farnesyl-proteine | |
US5981562A (en) | Inhibitors of farnesyl-protein transferase | |
EP0900081A1 (fr) | Inhibiteurs de farnesyl-proteine transferase | |
WO1996031525A2 (fr) | Inhibiteurs de la farnesyl-proteine transferase | |
CA2243272A1 (fr) | Inhibiteurs de farnesyl-proteine transferase | |
CA2243320A1 (fr) | Inhibiteurs de la farnesyle transferase | |
CA2243849A1 (fr) | Inhibiteurs de la farnesyl-proteine transferase | |
EP0837857A2 (fr) | Inhibiteurs de la farnesyl-proteine transferase | |
AU5428596A (en) | Inhibitors of farnesyl-protein transferase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |